Molecular and histological changes following central retinal artery occlusion in a mouse model

Experimental Eye Research

Volumn 87, Issue 4, 2008, Pages 327-333

  Goldenberg Cohen, Nitza ^a,b   Dadon, Shimrit ^b   Avraham, Bat Chen R ^b   Kramer, Michal ^a,b   Hasanreisoglu, Murat ^a,b   Eldar, Ido ^a,b   Weinberger, Dov ^a,b   Bahar, Irit ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

central artery occlusion; CRAO; molecular changes; mouse model

Indexed keywords

FIBRINOGEN; HEME OXYGENASE 1; MESSENGER RNA; ROSE BENGAL; THY 1 ANTIGEN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CENTRAL RETINA ARTERY OCCLUSION; CONTROLLED STUDY; FLUORESCENCE ANGIOGRAPHY; GENE EXPRESSION; HISTOLOGY; MOLECULAR SYSTEMATICS; MOUSE; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, THY-1; APOPTOSIS; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED C57BL; RETINA; RETINAL ARTERY OCCLUSION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 52049122811     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.06.014     Document Type: Article

References (53)

1. Aiello L.P. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies. Investig. Ophthalmol. Vis. Sci. 38 (1997) 1647-1652
2. Beschorner R., Adjodah D., Schwab J.M., Mittelbronn M., Pedal I., Mattern R., Schluesener H.J., and Meyermann R. Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol. (Berl) 100 (2000) 377-384
3. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., and Soares M.P. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192 (2000) 1015-1026
4. Brown G.C., and Magargal L.E. Central retinal artery obstruction and visual acuity. Ophthalmology 89 (1982) 14-19
5. Chidlow G., and Osborne N.N. Rat retinal ganglion cell loss caused by kainate, NMDA and ischemia correlates with a reduction in mRNA and protein of Thy-1 and neurofilament light. Brain Res. 963 (2003) 298-306
6. Chidlow G., Casson R., Sobrado-Calvo P., Vidal-Sanz M., and Osborne N.N. Measurement of retinal injury in the rat after optic nerve transection: an RT-PCR study. Mol. Vis. 11 (2005) 387-396
7. Cohan B.E., Pearch A.C., Jokelainen P.T., and Bohr D.F. Optic disc imaging in conscious rats and mice. Investig. Ophthalmol. Vis. Sci. 44 (2003) 160-163
8. Dabin I., and Barnstable C.J. Rat retinal Muller cells express Thy-1 following neuronal cell death. Glia 14 (1995) 23-32
9. Daugeliene L., Niwa M., Hara A., Matsuno H., Yamamoto T., Kitazawa Y., and Uematsu T. Transient ischemic injury in the rat retina caused by thrombotic occlusion-thrombolytic reperfusion. Investig. Ophthalmol. Vis. Sci. 41 (2000) 2743-2747
10. Ding K., Scortegagna M., Seaman R., Birch D.G., and Garcia J.A. Retinal disease in mice lacking hypoxia-inducible transcription factor-2alpha. Investig. Ophthalmol. Vis. Sci. 46 (2005) 1010-1016
11. Ferrara N., Houck K., Jakeman L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13 (1992) 18-32
12. Fu R., Zhao Z.Q., Zhao H.Y., Zhao J.S., and Zhu X.L. Expression of heme oxygenase-1 protein and messenger RNA in permanent cerebral ischemia in rats. Neurol. Res. 28 (2006) 38-45
13. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., and Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25 4 (2001) 386-401
14. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., Bauer C., Gassmann M., and Reme C.E. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8 (2002) 718-724
15. Hayreh S.S., and Jonas J.B. Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: an experimental study in rhesus monkeys. Am. J. Ophthalmol. 129 (2000) 786-795
16. Hayreh S.S., Zimmerman M.B., Kimura A., and Sanon A. Central retinal artery occlusion. Retinal survival time. Exp. Eye. Res. 78 (2004) 723-736
17. Huang L.E., Arany Z., Livingston D.M., and Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271 (1996) 32253-32259
18. Huang W., Fileta J., Guo Y., and Grosskreutz C.L. Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma. Curr. Eye Res. 31 (2006) 265-271
19. Iliaki O.E., Naoumidi I.I., Tsilimbaris M.K., and Pallikaris I.G. Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminum sulfonated phthalocyanine and a diode laser. Lasers Surg. Med. 19 (1996) 311-323
20. Imaizumi Y., Mizushima H., Dohi K., Ohtaki H., Funahashi H., and Shioda S. Hippocampal heme oxygenase-1 in a murine cardiac arrest model. Acta Neurochir. Suppl. 86 (2003) 101-103
21. Jin K.L., Mao X.O., Nagayama T., Goldsmith P.C., and Greenberg D.A. Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. Neuroscience 99 (2000) 577-585
22. Jonas J.B., and Hayreh S.S. Optic disk morphology in experimental central retinal artery occlusion in rhesus monkeys. Am. J. Ophthalmol. 127 (1999) 523-530
23. Kallio P.J., Pongratz I., Gradin K., McGuire J., and Poellinger L. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5667-5672
24. Kattah J.C., Wang D.Z., and Reddy C. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch. Ophthalmol. 120 (2002) 1234-1236
25. Kaur C., Sivakumar V., and Foulds W.S. Early response of neurons and glial cells to hypoxia in the retina. Investig. Ophthalmol. Vis. Sci. 47 (2006) 1126-1141
26. Lafuente M.P., Villegas-Perez M.P., Selles-Navarro I., Mayor-Torroglosa S., Miralles de Imperial J., and Vidal-Sanz M. Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience 109 (2002) 157-168
27. Lang G.E., and Spraul C.W. Risk factors for retinal occlusive diseases. Klin. Monatsbl. Augenheilkd. 211 (1997) 217-226
28. Lee P.J., Jiang B.H., Chin B.Y., Iyer N.V., Alam J., Semenza G.L., and Choi A.M. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272 (1997) 5375-5381
29. Lennmyr F., Terent A., Syvanen A.C., and Barbany G. Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat. Acta Anaesthesiol. Scand. 49 (2005) 488-493
30. Levy A.P., Levy N.S., Wegner S., and Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270 (1995) 13333-13340
31. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 517-554
32. Nag S., Takahashi J.L., and Kilty D.W. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J. Neuropathol. Exp. Neurol. 56 (1997) 912-921
33. Osborne N.N., Wood J.P., Cupido A., Melena J., and Chidlow G. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity. Investig. Ophthalmol. Vis. Sci. 43 (2002) 1456-1464
34. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., and Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6 (2000) 422-428
35. Ottino P., Finley J., Rojo E., Ottlecz A., Lambrou G.N., Bazan H.E., and Bazan N.G. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: involvement of cytosolic phospholipase A2 activity. Mol. Vis. 10 (2004) 341-350
36. Pe'er J., Shweiki D., Itin A., Hemo I., Gnessin H., and Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab. Investig. 72 (1995) 638-645
37. Plate K.H., Breier G., Weich H.A., and Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359 (1992) 845-848
38. Rosenstein J.M., and Krum J.M. New roles for VEGF in nervous tissue - beyond blood vessels. Exp. Neurol. 187 (2004) 246-253
39. Rumelt S., and Brown G.C. Update on treatment of retinal arterial occlusions. Curr. Opin. Ophthalmol. 14 (2003) 139-141
40. Schlamp C.L., Johnson E.C., Li Y., Morrison J.C., and Nickells R.W. Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Mol. Vis. 7 (2001) 192-201
41. Scortegagna M., Ding K., Oktay Y., Gaur A., Thurmond F., Yan L.J., Marck B.T., Matsumoto A.M., Shelton J.M., Richardson J.A., Bennett M.J., and Garcia J.A. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat. Genet. 35 (2003) 331-340
42. Semenza G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19 (2004) 176-182
43. Sharma S. Retinal artery obstruction. In: Schachet A.P. (Ed) (2001), Mosby, St. Louis 1350-1367
44. Shima D.T., Gougos A., Miller J.W., Tolentino M., Robinson G., Adamis A.P., and D'Amore P.A. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. Investig. Ophthalmol. Vis. Sci. 37 (1996) 1334-1340
45. Simpson D.A., Murphy G.M., Bhaduri T., Gardiner T.A., Archer D.B., and Stitt A.W. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. Biochem. Biophys. Res. Commun. 262 (1999) 333-340
46. Steuerwald N., Cohen J., Herrera R.J., and Brenner C.A. Quantification of mRNA in single oocytes and embryos by real-time rapid cycle fluorescence monitored RT-PCR. Mol. Hum. Reprod. 6 (2000) 448-453
47. Tang Y., Pacary E., Freret T., Divoux D., Petit E., Schumann-Bard P., and Bernaudin M. Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol. Dis. 21 (2006) 18-28
48. Tsurui Y., Sho M., Kuzumoto Y., Hamada K., Akashi S., Kashizuka H., Ikeda N., Nomi T., Mizuno T., Kanehiro H., and Nakajima Y. Dual role of vascular endothelial growth factor in hepatic ischemia-reperfusion injury. Transplantation 79 (2005) 1110-1115
49. 2 tension. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 5510-5514
50. 2-regulated gene expression. FASEB. J. 16 (2002) 1151-1162
51. Wiesener M.S., Turley H., Allen W.E., Willam C., Eckardt K.U., Talks K.L., Wood S.M., Gatter K.C., Harris A.L., Pugh C.W., Ratcliffe P.J., and Maxwell P.H. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92 (1998) 2260-2268
52. Yuzurihara D., and Iijima H. Visual outcome in central retinal and branch retinal artery occlusion. Jpn. J. Ophthalmol. 48 (2004) 490-492
53. Zhang Y., Cho C.H., Atchaneeyasakul L.O., McFarland T., Appukuttan B., and Stout J.T. Activation of the mitochondrial apoptotic pathway in a rat model of central retinal artery occlusion. Investig. Ophthalmol. Vis. Sci. 46 (2005) 2133-2139